Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:2673:317-327.
doi: 10.1007/978-1-0716-3239-0_22.

A Web-Based Method for the Identification of IL6-Based Immunotoxicity in Vaccine Candidates

Anjali Dhall #  1 , Sumeet Patiyal #  1 , Neelam Sharma  1 , Salman Sadullah Usmani  1 , Gajendra P S Raghava  2
Affiliations

A Web-Based Method for the Identification of IL6-Based Immunotoxicity in Vaccine Candidates

Anjali Dhall et al. Methods Mol Biol. 2023.

Abstract

Interleukin 6 (IL6) is a major pro-inflammatory cytokine that plays a pivotal role in both innate and adaptive immune responses. In the past, a number of studies reported that high level of IL6 promotes the proliferation of cancer, autoimmune disorders, and cytokine storm in COVID-19 patients. Thus, it is extremely important to identify and remove the antigenic regions from a therapeutic protein or vaccine candidate that may induce IL6-associated immunotoxicity. In order to overcome this challenge, our group has developed a computational tool, IL6pred, for discovering IL6-inducing peptides in a vaccine candidate. The aim of this chapter is to describe the potential applications and methodology of IL6pred. It sheds light on the prediction, designing, and scanning modules of IL6pred webserver and standalone package ( https://webs.iiitd.edu.in/raghava/il6pred/ ).

Keywords: Cytokines; IL6-inducing peptides; Immunotoxicity; Therapeutic peptides; Vaccine candidate.

PubMed Disclaimer

References

    1. Pulendran B, Ahmed R (2011) Immunological mechanisms of vaccination. Nat Immunol 12(6):509–517. https://doi.org/10.1038/ni.2039 - DOI - PubMed - PMC
    1. Cid R, Bolivar J (2021) Platforms for production of protein-based vaccines: from classical to next-generation strategies. Biomol Ther 11(8). https://doi.org/10.3390/biom11081072
    1. Usmani SS, Raghava GPS (2020) Potential challenges for coronavirus (SARS-CoV-2) vaccines under trial. Front Immunol 11:561851. https://doi.org/10.3389/fimmu.2020.561851 - DOI - PubMed - PMC
    1. Elhay MJ, Andersen P (1997) Immunological requirements for a subunit vaccine against tuberculosis. Immunol Cell Biol 75(6):595–603. https://doi.org/10.1038/icb.1997.94 - DOI - PubMed
    1. Andersen P, Doherty TM (2005) TB subunit vaccines--putting the pieces together. Microbes Infect 7(5–6):911–921. https://doi.org/10.1016/j.micinf.2005.03.013 - DOI - PubMed

Publication types

LinkOut - more resources